Abstract
The regulation of the dopamine transporter (DAT) impacts extracellular dopamine levels after release from dopaminergic neurons. Furthermore, a variety of protein partners have been identified that can interact with and modulate DAT function. In this study we show that DJ-1 can potentially modulate DAT function. Co-expression of DAT and DJ-1 in HEK-293T cells leads to an increase in [3H] dopamine uptake that does not appear to be mediated by increased total DAT expression but rather through an increase in DAT cell surface localization. In addition, through a series of GST affinity purifications and co-immunoprecipitations, we provide evidence that the DAT can be found in a complex with DJ-1, which involve distinct regions within both DAT and DJ-1. Using in vitro binding experiments we also show that this complex can be formed in part by a direct interaction between DAT and DJ-1. Co-expression of a mini-gene that can disrupt the DAT/DJ-1 complex appears to block the increase in [3H] dopamine uptake by DJ-1. Mutations in DJ-1 have been linked to familial forms of Parkinson’s disease, yet the normal physiological function of DJ-1 remains unclear. Our study suggests that DJ-1 may also play a role in regulating dopamine levels by modifying DAT activity.
Highlights
Dopaminergic neurotransmission is mediated by volume transmission that is largely extrasynaptic and is regulated by the levels of dopamine (DA) in the extracellular space [1,2,3,4,5,6,7,8]
Studies have shown that DJ-1 can interact with a wide variety of proteins including apoptosis signal-regulating kinase 1 [87], Hsp70 [88], α-synuclein [84,89,90,91], Daxx [78], MEKK1 [92], DJBP [76], HIPK1 [79], Topors/ p53BP3 [93], PIASxα [94] and TTRAP [95]
DJ-1 is expressed in the terminals of DA neurons [96] and DJ-1 null mice appear to exhibit increased DA reuptake [54,56] while exhibiting decreased D2 autoreceptor function [54,57], two key elements in regulating DA levels, which corresponds to increased DA tissue content in mice lacking DJ-1
Summary
Dopaminergic neurotransmission is mediated by volume transmission that is largely extrasynaptic and is regulated by the levels of dopamine (DA) in the extracellular space [1,2,3,4,5,6,7,8]. One of the major mechanisms for regulating DA levels is through reuptake via the dopamine transporter (DAT). In addition to DA, the DAT facilitates the reuptake of the neurotoxin 1-methy-4-phenylpyridinium (MPP+), which induces symptoms resembling Parkinson’s disease (PD) [9,10,11,12]. DAT regulation can be mediated by various means including activation of PKC [17,18,19,20,21,22], PKA [22,23,24,25], CaMKII [25,26,27,28] and tyrosine kinase [29,30,31,32]. DAT endocytosis has been demonstrated to occur by ubiquitination
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.